[ad_1]
Drug pricing regulator NPPA has fastened the retail costs for 84 drug formulations, together with these used for therapy of diabetes, headache and hypertension.
The Nationwide Pharmaceutical Pricing Authority (NPPA) has additionally fastened the costs of formulations indicated to cut back elevated ldl cholesterol and triglycerides ranges, amongst others.
In train of the powers conferred by the Medicine (Costs Management) Order, 2013, the NPPA has fastened the retail costs of the drugs, the regulator mentioned in a notification.
As per the order, a single pill of Voglibose and (SR) Metformin Hydrochloride will value Rs 10.47, excluding GST.
Equally, the worth of Paracetamol and Caffeine has been fastened at Rs 2.88 per pill. Apart from, the worth of 1 Rosuvastatin Aspirin and Clopidogrel capsule has been fastened at Rs 13.91.
In a separate notification, NPPA mentioned it has prolonged the revised ceiling worth of liquid medical oxygen and oxygen inhalation (medicinal fuel) until September 30 this 12 months.
The NPPA is remitted to repair/revise the costs of managed bulk medication and formulations and implement costs and availability of the medicines within the nation. It additionally screens the costs of decontrolled medication with a view to maintain them at affordable ranges.
The regulator implements and enforces the provisions of the Medicine (Costs Management) Order. It is usually entrusted with the duty of recovering quantities overcharged by producers for the managed medication.
[ad_2]
Source link